Description
Supply BMS-986165 Deucravacitinib 98% BMS-986165 Powder CAS 1609392-27-9
Description
| Cas: | 1609392-27-9 | Purity: | 99% |
|---|---|---|---|
| MF: | C20H22N8O3 | MW: | 422.45 |
| COA: | AVAILABLE | COLOR: | WHITE |
| High Light: |
BMS 986165 Powder, Deucravacitinib 1609392-27-9 |
||
Supply BMS-986165 Deucravacitinib 98% BMS-986165 Powder CAS 1609392-27-9
| Name | BMS-986165 |
| Purity | 99% |
| Origin | China |
| COA | Available |
Deucravacitinib (BMS-986165) is the first and only novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor in clinical studies across multiple immune-mediated diseases. Deucravacitinib’s selectivity is driven by a unique mechanism of action that is distinct from other kinase inhibitors.
Tag:
